Joana Goncalves
Nessuna posizione attualmente
Patrimonio netto: 48 562 $ in data 31/03/2024
Profilo
Joana Goncalves worked as the Vice President-Medical Affairs & Neurology at Celgene Corp.
from 2014 to 2018.
Prior to that, she was the VP-Medical Strategy & Scientific Affairs at Leo Pharma, Inc. from 2012 to 2014.
Currently, she is serving as the Chief Medical Officer at CARA Therapeutics, Inc. since 2018.
Dr. Goncalves holds a doctorate degree from the University of Cape Town.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CARA THERAPEUTICS INC
0.10% | 05/04/2024 | 53 365 ( 0.10% ) | 48 562 $ | 31/03/2024 |
Precedenti posizioni note di Joana Goncalves
| Società | Posizione | Fine |
|---|---|---|
| CARA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 16/04/2024 |
| CELGENE | Chief Tech/Sci/R&D Officer | 01/10/2018 |
Leo Pharma, Inc.
 Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Chief Tech/Sci/R&D Officer | 01/04/2014 |
Formazione di Joana Goncalves
| University of Cape Town | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CARA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Retail Trade |
- Borsa valori
- Insiders
- Joana Goncalves
